$2.05
-0.01[-0.49%]
At close: Apr 18
$2.05
0[0.00%]
After Hours: 5:53PM EDT
Athira Pharma
(NASDAQ:ATHA)Athira Pharma Stock (NASDAQ:ATHA), Analyst Ratings, Price Targets, Predictions
Athira Pharma Inc has a consensus price target of $13, established from looking at the 11 latest analyst ratings. The last 3 analyst ratings were released from JMP Securities, Mizuho, and BTIG on August 11, 2023, May 15, 2023, and March 30, 2023. With an average price target of $11.33 between JMP Securities, Mizuho, and BTIG, there's an implied 452.85% upside for Athira Pharma Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
JMP Securities
Mizuho
BTIG
Stifel
Jefferies
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Athira Pharma
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 08/11/2023 | ATHA | Buy Now | Athira Pharma | $2.05 | 826.83% | JMP Securities | Jason Butler | $20 → $19 | Maintains | Outperform | Get Alert |
| 05/15/2023 | ATHA | Buy Now | Athira Pharma | $2.05 | 143.9% | Mizuho | Graig Suvannavejh | $6 → $5 | Maintains | Buy | Get Alert |
| 03/30/2023 | ATHA | Buy Now | Athira Pharma | $2.05 | 387.8% | BTIG | Thomas Shrader | $33 → $10 | Maintains | Buy | Get Alert |
| 03/24/2023 | ATHA | Buy Now | Athira Pharma | $2.05 | 875.61% | JMP Securities | Jason Butler | → $20 | Reiterates | → Market Outperform | Get Alert |
| 07/07/2022 | ATHA | Buy Now | Athira Pharma | $2.05 | 192.68% | Mizuho | Graig Suvannavejh | → $6 | Initiates | → Buy | Get Alert |
| 06/23/2022 | ATHA | Buy Now | Athira Pharma | $2.05 | 143.9% | Stifel | Paul Matteis | $36 → $5 | Downgrade | Buy → Hold | Get Alert |
| 06/23/2022 | ATHA | Buy Now | Athira Pharma | $2.05 | — | JMP Securities | Jason Butler | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 06/23/2022 | ATHA | Buy Now | Athira Pharma | $2.05 | 46.34% | Jefferies | Andrew Tsai | $32 → $3 | Downgrade | Buy → Hold | Get Alert |
| 05/10/2022 | ATHA | Buy Now | Athira Pharma | $2.05 | 1509.76% | BTIG | Thomas Shrader | → $33 | Initiates | → Buy | Get Alert |
| 04/21/2022 | ATHA | Buy Now | Athira Pharma | $2.05 | 1509.76% | Berenberg | Esther Hong | → $33 | Initiates | → Buy | Get Alert |
| 12/15/2021 | ATHA | Buy Now | Athira Pharma | $2.05 | 680.49% | Goldman Sachs | Corinne Jenkins | — | Initiates | → Neutral | Get Alert |
FAQ
What is the target price for Athira Pharma (ATHA)?
The latest price target for Athira Pharma (NASDAQ: ATHA) was reported by JMP Securities on August 11, 2023. The analyst firm set a price target for $19.00 expecting ATHA to rise to within 12 months (a possible 826.83% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Athira Pharma (ATHA)?
The latest analyst rating for Athira Pharma (NASDAQ: ATHA) was provided by JMP Securities, and Athira Pharma maintained their outperform rating.
When was the last upgrade for Athira Pharma (ATHA)?
There is no last upgrade for Athira Pharma.
When was the last downgrade for Athira Pharma (ATHA)?
The last downgrade for Athira Pharma Inc happened on June 23, 2022 when Stifel changed their price target from $36 to $5 for Athira Pharma Inc.
When is the next analyst rating going to be posted or updated for Athira Pharma (ATHA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Athira Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Athira Pharma was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
Is the Analyst Rating Athira Pharma (ATHA) correct?
While ratings are subjective and will change, the latest Athira Pharma (ATHA) rating was a maintained with a price target of $20.00 to $19.00. The current price Athira Pharma (ATHA) is trading at is $2.05, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.